Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT04007302
Eligibility Criteria:
Inclusion Criteria:
* The patient must have given free and informed consent and signed the consent
* The patient must be a member or beneficiary of a health insurance plan
* The patient is available for a 3-day follow-up
* The patient is between 18 and 75 years old
* Disabling lumbar pain beyond three months
Exclusion Criteria:
* Subject participates in another intervention study
* Subject is in an exclusion period determined by a previous study
* The subject is under the protection of justice, guardianship or curatorship
* Subject refuses to sign consent
* It is impossible to provide informed information about the subject
* The subject is unable to complete the study questionnaires
* The patient is pregnant, parturient, or breastfeeding
* The subject has a contraindication (or incompatible drug combination) for a treatment required for this study
* Recent involuntary weight loss
* Inflammatory schedule pain (predominantly nocturnal, requiring early morning rusting, improved by physical activity)
* Associated fever,
* Saddle anaesthesia
* Vesico-sphincterial disorders
* Typical root symptoms
* Systemic corticosteroid therapy
* History of cancer
* History of spinal trauma
* History of intravenous drug use
* Systemic corticosteroid therapy
* Surgical intervention of the spine or lower limbs
* Painful pathology of the lower limbs (coxarthrosis, gonarthrosis, vascular claudication or neurogenic when walking).
Exclusion criteria:
● Taking prescribed analgesic treatment after the inclusion procedure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04007302
Study Brief:
Protocol Section:
NCT04007302